Lumos Pharma lumos-pharma.com


Public list: Smart Money VCs (6326) Pharma Startups (6570) Rare Diseases (230)

Lumos Pharma is a clinical stage biopharmaceutical company committed to identifying, developing and commercializing therapies for patients and families living with rare diseases. Lumos strives to work with all stakeholders in the rare disease field, from universities to patient organizations.

Lumos Pharma is a clinical stage biopharmaceutical company committed to identifying, developing and commercializing therapies for patients and families living with rare diseases. Lumos strives to work with all stakeholders in the rare disease field, ...Show all

Company (IPO / Went public)

Phone: 512-215-2630

Fax:

4200 Marathon Blvd.
Suite 200
Austin, 78756
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lumos Pharma $48M Sep 30, 2019
Audentes Therapeutics $212.5M Dec 2, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lumos Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Synthesis of cyclocreatine and analogs thereof Sep 01, 2015 Dec 03, 2019 Patent
Synthesis of cyclocreatine and analogs thereof Aug 21, 2018 Aug 13, 2019 Patent
Detecting and treating growth hormone deficiency Sep 18, 2017 Oct 23, 2018 Patent
Synthesis of cyclocreatine and analogs thereof Mar 11, 2016 Sep 25, 2018 Patent
Detecting and treating growth hormone deficiency Sep 20, 2018 Application
See all 6 patents